Figure 2.

Association of JAM3 with prognosis of BC. (A and B) Univariate and multivariate Cox regression analysis; (C and D) Kaplan–Meier analysis for OS and PFS of JAM3 in BC; (E) Time-dependent ROC curves and AUC at 1-, 3-, and 5-year were used to evaluate the predictive value of JAM3; (F) Paired expression analyses of JAM3 in TCGA cohort for BC; (G) Difference in M6A methylation level of JAM3 between BC and normal samples; (H) The expression of JAM3 in pan-cancer. *P < 0.05, **P < 0.01 ***P < 0.001. OS: Overall survival; PFS: Progression-free survival; JAM3: Junctional adhesion molecule 3; TCGA: The Cancer Genome Atlas; ROC: Receiver operating characteristic; AUC: Area under the curve; JAM3: Junctional adhesion molecule 3; BC: Bladder cancer.